Steve Aselage, Director at Acer Therapeutics Inc. (ACER), bought 45,000 shares at $3.50 ($158K) on 2020-07-24, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |